These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33649198)

  • 1. Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia.
    Chang YL; Rossetti M; Gjertson DW; Rubbi L; Thompson M; Montoya DJ; Morselli M; Ruffin F; Hoffmann A; Pellegrini M; Fowler VG; Yeaman MR; Reed EF;
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.
    Mba Medie F; Sharma-Kuinkel BK; Ruffin F; Chan LC; Rossetti M; Chang YL; Park LP; Bayer AS; Filler SG; Ahn R; Reed EF; Gjertson D; Yeaman MR; Fowler VG;
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20087-20096. PubMed ID: 31527248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia.
    Parmar R; Pickering H; Ahn R; Rossetti M; Gjertson DW; Ruffin F; Chan LC; Fowler VG; Yeaman MR; Reed EF;
    Front Immunol; 2024; 15():1373553. PubMed ID: 38846955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
    Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
    PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R; So H; Seo E; Kim M; Lee J
    PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
    Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
    Roghmann MC
    Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Stringent Response Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection Through the Purine Biosynthetic Pathway.
    Li L; Bayer AS; Cheung A; Lu L; Abdelhady W; Donegan NP; Hong JI; Yeaman MR; Xiong YQ
    J Infect Dis; 2020 Sep; 222(7):1188-1198. PubMed ID: 32333768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
    Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
    Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Okumura CY; Thienphrapa W; Olson J; Nonejuie P; Dam Q; Dhand A; Pogliano J; Yeaman MR; Hensler ME; Bayer AS; Nizet V
    J Mol Med (Berl); 2014 Feb; 92(2):139-49. PubMed ID: 24297496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying determinants of persistent MRSA bacteremia using mathematical modeling.
    Mikkaichi T; Yeaman MR; Hoffmann A;
    PLoS Comput Biol; 2019 Jul; 15(7):e1007087. PubMed ID: 31295255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.
    Holland TL; Bayer AS; Fowler VG
    Clin Infect Dis; 2022 Oct; 75(9):1668-1674. PubMed ID: 35535790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes.
    Lee YM; Chong YP; Kim M; Eom Y; Kim ES; Kim M; Park KH; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):773-781. PubMed ID: 31873861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020.
    Chen CH; Wu PH; Lu MC; Ho MW; Hsueh PR;
    Int J Antimicrob Agents; 2023 Apr; 61(4):106745. PubMed ID: 36758774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.
    Park SY; Chong YP; Park HJ; Park KH; Moon SM; Jeong JY; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
    Infection; 2013 Feb; 41(1):111-9. PubMed ID: 23065454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
    Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
    Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.